Investing Profile

Simeon J. George

Photo of Simeon J. George, Partner at SR One

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
SR One Partner
15
CompanyStageDateRound SizeTotal Raised
Turning Point Therapeutics
Series CMay 2017$45M
$45M
Co-investors: Carl Gordon (OrbiMed), Hongbo Lu (Vivo Capital)
Progyny
Series BMay 2017$10M
Series BJul 2016$15M
$25M
Co-investors: Beth Seidenberg (Kleiner Perkins)
CRISPR Therapeutics
Funding RoundApr 2015$64M
$130M
Co-investors: Ali Behbahani (New Enterprise Associates (NEA)), Kurt von Emster (Abingworth)
Principia Biopharma
Series BApr 2014$50M
Series AOct 2012$13M
$63M
Co-investors: Nassim Usman (Morgenthaler Ventures), Mike Dybbs (Samsara BioCapital)
Bird Rock Bio
Series BMar 2014$15M
Series AMay 2009$13M
$61M
Co-investors: Andrew Schwab (5am Ventures), Richard Ulevitch (5am Ventures), Roel Bulthuis (INKEF Capital)
Genocea Biosciences
Series COct 2012$30M
Series BJan 2011$35M
Series BDec 2009€17M
€29M
$65M
Co-investors: Philippe Peltier (Kurma Partners), Asish Xavier (Johnson & Johnson Innovation), Kevin Bitterman (Atlas Venture), Ling Wong (Highbury Group)
HTG Molecular Diagnostics
Series DJun 2011$500K
Series DFeb 2011$16M
$16M
Semprus BioSciences
Series BDec 2010$18M
$18M
Co-investors: Scott Rocklage (5am Ventures)